BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34332627)

  • 1. Chromatin insulation dynamics in glioblastoma: challenges and future perspectives of precision oncology.
    Sesé B; Ensenyat-Mendez M; Iñiguez S; Llinàs-Arias P; Marzese DM
    Clin Epigenetics; 2021 Jul; 13(1):150. PubMed ID: 34332627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulator dysfunction and oncogene activation in IDH mutant gliomas.
    Flavahan WA; Drier Y; Liau BB; Gillespie SM; Venteicher AS; Stemmer-Rachamimov AO; Suvà ML; Bernstein BE
    Nature; 2016 Jan; 529(7584):110-4. PubMed ID: 26700815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory networks driving expression of genes critical for glioblastoma are controlled by the transcription factor c-Jun and the pre-existing epigenetic modifications.
    Roura AJ; Szadkowska P; Poleszak K; Dabrowski MJ; Ellert-Miklaszewska A; Wojnicki K; Ciechomska IA; Stepniak K; Kaminska B; Wojtas B
    Clin Epigenetics; 2023 Feb; 15(1):29. PubMed ID: 36850002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches.
    Uddin MS; Mamun AA; Alghamdi BS; Tewari D; Jeandet P; Sarwar MS; Ashraf GM
    Semin Cancer Biol; 2022 Aug; 83():100-120. PubMed ID: 33370605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis.
    Gonçalves CS; Xavier-Magalhães A; Martins EP; Pinto AA; Pires MM; Pinheiro C; Reis RM; Sousa N; Costa BM
    Mol Oncol; 2020 Jun; 14(6):1224-1241. PubMed ID: 31923345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Evolution of
    Draaisma K; Chatzipli A; Taphoorn M; Kerkhof M; Weyerbrock A; Sanson M; Hoeben A; Lukacova S; Lombardi G; Leenstra S; Hanse M; Fleischeuer R; Watts C; McAbee J; Angelopoulos N; Gorlia T; Golfinopoulos V; Kros JM; Verhaak RGW; Bours V; van den Bent MJ; McDermott U; Robe PA; French PJ
    J Clin Oncol; 2020 Jan; 38(1):81-99. PubMed ID: 31743054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
    Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
    Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature.
    Chiang JH; Cheng WS; Hood L; Tian Q
    OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping.
    Lyon JF; Vasudevaraja V; Mirchia K; Walker JM; Corona RJ; Chin LS; Tran I; Snuderl M; Richardson TE; Viapiano MS
    Acta Neuropathol Commun; 2021 Jun; 9(1):120. PubMed ID: 34193272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.
    Huang YC; Lai JC; Peng PH; Wei KC; Wu KJ
    Clin Epigenetics; 2021 Nov; 13(1):201. PubMed ID: 34732244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic mechanisms in glioblastoma multiforme.
    Nagarajan RP; Costello JF
    Semin Cancer Biol; 2009 Jun; 19(3):188-97. PubMed ID: 19429483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex mapping of chromatin accessibility and DNA methylation within targeted single molecules identifies epigenetic heterogeneity in neural stem cells and glioblastoma.
    Nabilsi NH; Deleyrolle LP; Darst RP; Riva A; Reynolds BA; Kladde MP
    Genome Res; 2014 Feb; 24(2):329-39. PubMed ID: 24105770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients.
    Yong WH; Shabihkhani M; Telesca D; Yang S; Tso JL; Menjivar JC; Wei B; Lucey GM; Mareninov S; Chen Z; Liau LM; Lai A; Nelson SF; Cloughesy TF; Tso CL
    PLoS One; 2015; 10(10):e0141334. PubMed ID: 26506620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation.
    Jha P; Pia Patric IR; Shukla S; Pathak P; Pal J; Sharma V; Thinagararanjan S; Santosh V; Suri V; Sharma MC; Arivazhagan A; Suri A; Gupta D; Somasundaram K; Sarkar C
    Neuro Oncol; 2014 Dec; 16(12):1607-17. PubMed ID: 24997139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 17. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification.
    Wenger A; Ferreyra Vega S; Kling T; Bontell TO; Jakola AS; Carén H
    Neuro Oncol; 2019 May; 21(5):616-627. PubMed ID: 30668814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promoter hypermethylation status of GATA6, MGMT, and FHIT in glioblastoma.
    Cecener G; Tunca B; Egeli U; Bekar A; Tezcan G; Erturk E; Bayram N; Tolunay S
    Cell Mol Neurobiol; 2012 Mar; 32(2):237-44. PubMed ID: 21928112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.